Skip to main content
Top

memo - Magazine of European Medical Oncology

Issue 1/2017

Content (12 Articles)

editorial

To print or not to print

Wolfgang Hilbe, Rupert Bartsch, Waltraud Radlherr

editorial

memo: Official journal of the OeGHO and CECOG

UIrich Jäger, Christoph C. Zielinski

editorial

memo: Spectacular developments during the last decade from the Section Editors’ point of view

Silvia Hofer, Eberhard Gunsilius, István Láng, Vladimir Moiseyenko

Open Access short review

Milestones in Chronic Lymphocytic Leukemia

Alexander Egle

short review

Milestones in myeloma

Niklas Zojer

Open Access short review

Milestones of the last 10 years

Christine Marosi, Matthias Preusser

Open Access short review

Milestones in the systemic treatment of lung cancer

Robert Pirker

short review

Breast cancer milestones 2007–2016

Kathrin Strasser-Weippl

short review

Milestones in gastric cancer

Ewald Wöll

short review

Milestones in advanced renal cell carcinoma

Dora Niedersuess-Beke

Open Access short review

Milestones in pathology—from histology to molecular biology

Leonhard Müllauer

Open Access comment

My personal highlights of ESMO 2016

M. Dediu, A. Gerger, N. Zojer, R. Bartsch

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine